miR-506 suppresses Non-Small Cell Lung Cancer (NSCLC) progression by regulating Tubby-like protein 3 (TULP3), inducing mitochondrial apoptosis, and in vivo studies confirm its ability to reduce tumor growth, highlighting its role in NSCLC therapy (16). Here, TULP3 is linked to neoplasm.